Specifically, tTg-IgA testing may be particularly valuable in patients with PsO who have comorbid autoimmune diseases, unexplained gastrointestinal symptoms, recurrent or refractory flare-ups, a strong family history of autoimmune conditions, or concurrent metabolic syndrome or T2DM. This evidence concerns the gene CD79A and autoimmune disease.